UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.712

Sortiert nach

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Annals of oncology, 2014-12, Vol.25 (12), p.2357-2362

2014

Volltextzugriff (PDF)

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

Annals of oncology, 2014-04, Vol.25 (4), p.808-815

2014

Volltextzugriff (PDF)

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

Annals of oncology, 2019-02, Vol.30 (2), p.325-331

2019

Volltextzugriff (PDF)

Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study

Annals of oncology, 2020-03, Vol.31 (3), p.412-421

2020

Volltextzugriff (PDF)

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Annals of oncology, 2018-07, Vol.29 (7), p.1541-1547

2018

Volltextzugriff (PDF)

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

Annals of oncology, 2017-03, Vol.28 (3), p.528-534

2017

Volltextzugriff (PDF)

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

Annals of oncology, 2017-04, Vol.28 (4), p.855-861

2017

Volltextzugriff (PDF)

Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs

Oncogene, 2009-08, Vol.28 (S1), p.S4-S13

Burris, 3rd, H A

2009

Volltextzugriff (PDF)

JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions

Annals of oncology, 2020-07, Vol.31 (7), p.861-872

2020

Volltextzugriff (PDF)

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors

Annals of oncology, 2015-01, Vol.26 (1), p.58-64

2015

Volltextzugriff (PDF)

Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer

Annals of oncology, 2015-04, Vol.26 (4), p.804-811

2015

Volltextzugriff (PDF)

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2403-2413

1997

Volltextzugriff (PDF)

Epidemiologic, Public Health, and Clinical Implications of Death Among Preterm Infants in the US

JAMA pediatrics, 2023-10, Vol.177 (10), p.1014

Burris, Heather H

2023

Volltextzugriff (PDF)

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Investigational new drugs, 2016-12, Vol.34 (6), p.740-749

2016

Volltextzugriff (PDF)

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Annals of oncology, 2003-12, Vol.14 (12), p.1735-1743

2003

Volltextzugriff (PDF)

A non-optimal cervicovaginal microbiota in pregnancy is associated with a distinct metabolomic signature among non-Hispanic Black individuals

Scientific reports, 2021-11, Vol.11 (1), p.22794-12, Article 22794

2021

Volltextzugriff (PDF)

Second trimester extracellular microRNAs in maternal blood and fetal growth: An exploratory study

Epigenetics, 2017-09, Vol.12 (9), p.804-810

2017

Volltextzugriff (PDF)

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Annals of oncology, 2016-11, Vol.27 (11), p.2124-2130

2016

Volltextzugriff (PDF)

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Annals of oncology, 2019-11, Vol.30 (11), p.1842-1842

2019

Volltextzugriff (PDF)

Prenatal lead exposure modifies the effect of shorter gestation on increased blood pressure in children

Environment international, 2018-11, Vol.120, p.464-471

2018

Volltextzugriff (PDF)

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies

British journal of cancer, 2014-05, Vol.110 (11), p.2647-2654

2014

Volltextzugriff (PDF)

Disparities in antidepressant use in pregnancy

Journal of perinatology, 2015-04, Vol.35 (4), p.246-251

2015

Volltextzugriff (PDF)

The Uptake of Telemedicine in Obstetric Care During the Early Acute Phase of the Coronavirus 2019 Pandemic

Telemedicine journal and e-health, 2023-04, Vol.29 (4), p.617

2023

Volltextzugriff (PDF)

Associations of neighborhood social vulnerability with emergency department visits and readmissions among infants with bronchopulmonary dysplasia

Journal of perinatology, 2023-10, Vol.43 (10), p.1308-1313

2023

Volltextzugriff (PDF)

The impact of postpartum social support on postpartum mental health outcomes during the COVID-19 pandemic

Archives of women's mental health, 2023-08, Vol.26 (4), p.531-541

2023

Volltextzugriff (PDF)

1 – 25 von 1.712

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.555)
Mit Volltextzugriff
(1.477)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.709)
Japanisch
(117)
Croatian
(1)
Französisch
(1)
Deutsch
(1)
Russisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs

JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors

Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Epidemiologic, Public Health, and Clinical Implications of Death Among Preterm Infants in the US

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

A non-optimal cervicovaginal microbiota in pregnancy is associated with a distinct metabolomic signature among non-Hispanic Black individuals

Second trimester extracellular microRNAs in maternal blood and fetal growth: An exploratory study

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Prenatal lead exposure modifies the effect of shorter gestation on increased blood pressure in children

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies

Disparities in antidepressant use in pregnancy

The Uptake of Telemedicine in Obstetric Care During the Early Acute Phase of the Coronavirus 2019 Pandemic

Associations of neighborhood social vulnerability with emergency department visits and readmissions among infants with bronchopulmonary dysplasia

The impact of postpartum social support on postpartum mental health outcomes during the COVID-19 pandemic

Suchergebnisse filtern